Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model

Journal of Infectious Diseases

Volumn 193, Issue 7, 2006, Pages 963-970

  Barber, Sheila A ^a   Gama, Lucio ^a   Dudaronek, Justyna M ^a   Voelker, Tauni ^a   Tarwater, Patrick M ^b   Clements, Janice E ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CCAAT ENHANCER BINDING PROTEIN BETA; HISTONE ACETYLTRANSFERASE; TRANSCRIPTION FACTOR;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLIA CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPRECIPITATION; INFECTION CONTROL; LATENT VIRUS INFECTION; LONG TERMINAL REPEAT; MACACA; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS LATENCY; VIRUS REPLICATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DNA, VIRAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMANS; IMMUNITY, NATURAL; INTERFERON-BETA; MACACA NEMESTRINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TERMINAL REPEAT SEQUENCES; VIRAL PROTEINS; VIRUS LATENCY;

EID: 33645365759     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/500983     Document Type: Article

References (56)

1. Williams KC, Corey S, Westmoreland SV, et al. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 2001; 193:905-15.
2. Cosenza MA, Zhao ML, Si Q, Lee SC. Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol 2002;12:442-55.
3. Lassmann H, Schmied M, Vass K, Hickey WF. Bone marrow derived elements and resident microglia in brain inflammation. Glia 1993;7: 19-24.
4. Unger ER, Sung IH, Manivel IC, Chenggis ML, Blazar BR, Krivit W. Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: a Y-chromosome specific in situ hybridization study. J Neuropathol Exp Neurol 1993;52:460-70.
5. Hickey WF. Basic principles of immunological surveillance of the normal central nervous system. Glia 2001;36:118-24.
6. Ho DD, Sarngadharan MG, Resnick L, Dimarzoveronese F, Rota TR, Hirsch MS. Primary human T-lymphotropic virus type III infection. Ann Intern Med 1985;103:880-3.
7. Chiodi F, Albert J, Olausson E, et al. Isolation frequency of human immunodeficiency virus from cerebrospinal fluid and blood of patients with varying severity of HIV infection. AIDS Res Hum Retroviruses 1988;4:351-8.
8. Davis LE, Hjelle BL, Miller VE, et al. Early viral brain invasion in latrogenic human immunodeficiency virus infection. Neurology 1992;42: 1736-9.
9. An SF, Groves M, Gray F, Scaravilli F. Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J Neuropathol Exp Neurol 1999;58:1156-62.
10. Murray EA, Rausch DM, Lendvay J, Sharer LR, Eiden LE. Cognitive and motor impairments associated with SIV infection in rhesus monkeys. Science 1992;255:1246-9.
11. Sharer LR, Baskin GB, Cho ES, Murphey-Corb M, Blumberg BM, Epstein LG. Comparison of simian immunodeficiency virus and human immunodeficiency virus encephalitides in the immature host. Ann Neurol 1988;23(Suppl):S108-12.
12. Zink MC, Suryanarayana K, Mankowski JL, et al. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol 1999;73:10480-8.
13. Flaherty MT, Hauer DA, Mankowski JL, Zink MC, Clements JE. Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J Virol 1997;71:5790-8.
14. Mankowski JL, Flaherty MT, Spelman JP, et al. Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J Virol 1997;71:6055-60.
15. Zink MC, Amedee AM, Mankowski JL, et al. Pathogenesis of SIV encephalitis: selection and replication of neurovirulent SIV. Am J Pathol 1997;151:793-803.
16. Mankowski JL, Queen SE, Tarwater PM, Fox KJ, Perry VH. Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J Neuropathol Exp Neurol 2002;61:85-90.
17. Weed MR, Hienz RD, Brady JV, et al. Central nervous system correlates of behavioral deficits following simian immunodeficiency virus infection. J Neurovirol 2003;9:452-64.
18. Clements JE, Babas T, Mankowski JL, et al. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J Infect Dis 2002;186:905-13.
19. Griffin DE. Immune responses to RNA-virus infections of the CNS. Nat Rev Immunol 2003;3:493-502.
20. Barber SA, Herbst DS, Bullock BT, Gama L, Clements JE. Innate immune responses and control of acute simian immunodeficiency virus replication in the central nervous system. J Neurovirol 2004; 10(Suppl 1):15-20.
21. Kornbluth RS, Oh PS, Munis JR, Cleveland PH, Richman DD. The role of interferons in the control of HIV replication in macrophages. Clin Immunol Immunopathol 1990;54:200-19.
22. Honda Y, Rogers L, Nakata K, et al. Type I interferon induces inhibitory 16-kD CCAAT/enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J Exp Med 1998;188:1255-65.
23. Weiden M, Tanaka N, Qiao Y, et al. Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein beta expression. J Immunol 2000;165:2028-39.
24. Descombes P, Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 1991;67:569-79.
25. Henderson AJ, Zou X, Calame KL. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol 1995;69:5337-44.
26. Henderson AJ, Connor RI, Calame KL. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 1996;5:91-101.
27. + T cells. Proc Natl Acad Sci USA 1997;94:8714-9.
28. Abel K, Alegria-Hartman MJ, Rothaeusler K, Marthas M, Miller CJ. The relationship between simian immunodeficiency virus RNA levels and the mRNA levels of alpha/beta interferons (IFN-alpha/beta) and IFN-alpha/beta-inducible Mx in lymphoid tissues of rhesus macaques during acute and chronic infection. J Virol 2002;76:8433-45.
29. Flaherty MT, Barber SA, Clements JE. Neurovirulent simian immunodeficiency virus incorporates a Nef-associated kinase activity into virions. AIDS Res Hum Retroviruses 1998;14:163-70.
30. Rue SM, Roos JW, Tarwater PM, Clements JE, Barber SA. Phosphorylation and proteolytic cleavage of gag proteins in budded simian immunodeficiency virus. J Virol 2005;79:2484-92.
31. Roos JW, Maughan MF, Liao Z, Hildreth JE, Clements JE. LuSIV cells: 3 reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication. Virology 2000;273:307-15.
32. Perera PY, Qureshi N, Vogel SN. Paclitaxel (Taxol)-induced NF-kappaB translocation in murine macrophages. Infect Immun 1996;64:878-84.
33. Orlando V, Strutt H, Paro R. Analysis of chromatin structure by in vivo formaldehyde cross-linking. Methods 1997;11:205-14.
34. Kracke A, von Wussow P, Al-Masri AN, Dalley G, Windhagen A, Heidenreich F. Mx proteins in blood leukocytes for monitoring interferon beta-1b therapy in patients with MS. Neurology 2000;54:193-9.
35. Ossipow V, Descombes P, Schibler U. CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc Natl Acad Sci USA 1993;90:8219-23.
36. Yang Y, Tesmer VM, Bina M. Regulation of HIV-1 transcription in activated monocyte macrophages. Virology 2002;299:256-65.
37. Anderson MG, Clements JE. Comparison of the transcriptional activity of the long terminal repeats of simian immunodeficiency viruses SIVmac251 and SIVmac239 in T-cell lines and macrophage cell lines. J Virol 1991;65:51-60.
38. Nonnemacher MR, Hogan TH, Quiterio S, Wigdahl B, Henderson A, Krebs FC. Identification of binding sites for members of the CCAAT/enhancer binding protein transcription factor family in the simian immunodeficiency virus long terminal repeat. Biomed Pharmacother 2003;57:34-40.
39. Lusic M, Marcello A, Cereseto A, Giacca M. Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J 2003;22:6550-61.
40. Marcello A, Lusic M, Pegoraro G, Pellegrini V, Beltram F, Giacca M. Nuclear organization and the control of HIV-1 transcription. Gene 2004;326:1-11.
41. Quivy V, Van Lint C. Diversity of acetylation targets and roles in transcriptional regulation: the human immunodeficiency virus type 1 promoter as a model system. Biochem Pharmacol 2002;64:925-34.
42. Lee ES, Sarma D, Zhou H, Henderson AJ. CCAAT/enhancer binding proteins are not required for HIV-1 entry but regulate proviral transcription by recruiting coactivators to the long-terminal repeat in monocytic cells. Virology 2002;299:20-31.
43. El Kharroubi A, Piras G, Zensen R, Martin MA. Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter. Mol Cell Biol 1998;18:2535-44.
44. Demarchi F, D'Agaro P, Falaschi A, Giacca M. In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1. J Virol 1993;67:7450-60.
45. Shen A, Zink MC, Mankowski JL, et al. Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy. J Virol 2003;77:4938-49.
46. Persaud D, Zhou Y, Siliciano JM, Siliciano RF. Latency in human immunodeficiency virus type 1 infection: no easy answers. J Virol 2003;77: 1659-65.
47. Akira S, Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 1992;127:25-50.
48. Poli V. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 1998;273:29279-82.
49. Ramji DP, Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 2002;365:561-75.
50. Liu JS, Amaral TD, Brosnan CF, Lee SC. IFNs are critical regulators of IL-1 receptor antagonist and IL-1 expression in human microglia. J Immunol 1998;161:1989-96.
51. Pope RM, Leutz A, Ness SA. C/EBP beta regulation of the tumor necrosis factor alpha gene. J Clin Invest 1994;94:1449-55.
52. Hoshino Y, Nakata K, Hoshino S, et al. Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J Exp Med 2002;195:495-505.
53. Aweeka F, Jayewardene A, Staprans S, et al. Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1-infected patients with and without AIDS dementia complex. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:39-43.
54. Foudraine NA, Hoetelmans RM, Lange JM, et al. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet 1998;351:1547-51.
55. Kim RB, Fromm MF, Wandel C, et al. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest 1998;101:289-94.
56. Kravcik S, Gallicano K, Roth V, et al. Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir. J Acquir Immune Defic Syndr 1999;21:371-5.